4.7 Article

Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus

Journal

SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-43820-4

Keywords

-

Funding

  1. SG's UCL Impact PhD studentship
  2. MRC [MR/M00676X/1]
  3. Wellcome Trust [080174, 098327, 098328, 098330/Z/12/Z, FC001194]
  4. AnEUploidy integrated project (EU Framework 6)
  5. Medical Research Council [U117527252, G0601056]
  6. Alzheimer's Research UK
  7. Alzheimer's Society
  8. Francis Crick Institute from UK Medical Research Council [FC001194]
  9. Cancer Research UK [FC001194]
  10. Alzheimer's Society studentship
  11. MRC [MR/M00676X/1, G0601056, UKDRI-1014] Funding Source: UKRI

Ask authors/readers for more resources

Pathological mechanisms underlying Down syndrome (DS)/Trisomy 21, including dysregulation of essential signalling processes remain poorly understood. Combining bioinformatics with RNA and protein analysis, we identified downregulation of the Wnt/beta-catenin pathway in the hippocampus of adult DS individuals with Alzheimer's disease and the 'Tc1' DS mouse model. Providing a potential underlying molecular pathway, we demonstrate that the chromosome 21 kinase DYRK1A regulates Wnt signalling via a novel bimodal mechanism. Under basal conditions, DYRK1A is a negative regulator of Wnt/beta-catenin. Following pathway activation, however, DYRK1A exerts the opposite effect, increasing signalling activity. In summary, we identified downregulation of hippocampal Wnt/beta-catenin signalling in DS, possibly mediated by a dose dependent effect of the chromosome 21-encoded kinase DYRK1A. Overall, we propose that dosage imbalance of the Hsa21 gene DYRK1A affects downstream Wnt target genes. Therefore, modulation of Wnt signalling may open unexplored avenues for DS and Alzheimer's disease treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

The development of inhibitors of leucine-rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play

Sonia Azeggagh, Daniel C. Berwick

Summary: Current therapeutic approaches for Parkinson's disease focus on symptom relief rather than disease progression. Inhibition of LRRK2 function is a promising strategy due to its role in familial and idiopathic Parkinson's disease. Progress has been made in finding effective LRRK2 inhibitors, but the complexity of LRRK2 presents challenges and opportunities for unintended consequences. Multiple molecules are in clinical trials, providing cause for optimism in the search for alternative treatment options.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Biotechnology & Applied Microbiology

Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment

Clement Danis, Elian Dupre, Orgeta Zejneli, Raphaelle Caillierez, Alexis Arrial, Severine Begard, Justine Mortelecque, Sabiha Eddarkaoui, Anne Loyens, Francois-Xavier Cantrelle, Xavier Hanoulle, Jean-Christophe Rain, Morvane Colin, Luc Buee, Isabelle Landrieu

Summary: The study demonstrates the effectiveness of VHH Z70 in inhibiting Tau aggregation and reducing pathological Tau accumulation in brain neurons. By specifically targeting Tau within cells, VHH Z70 provides an immunological tool for targeting the intra-cellular compartment in tauopathies.

MOLECULAR THERAPY (2022)

Article Multidisciplinary Sciences

ER proteins decipher the tubulin code to regulate organelle distribution

Pengli Zheng, Christopher J. Obara, Ewa Szczesna, Jonathon Nixon-Abell, Kishore K. Mahalingan, Antonina Roll-Mecak, Jennifer Lippincott-Schwartz, Craig Blackstone

Summary: This study demonstrates that three membrane-bound endoplasmic reticulum proteins interact preferentially with different microtubule populations, influencing organelle positioning and distribution in cells.

NATURE (2022)

Article Biochemistry & Molecular Biology

Transverse endoplasmic reticulum expansion in hereditary spastic paraplegia corticospinal axons

Peng-Peng Zhu, Hui-Fang Hung, Natalia Batchenkova, Jonathon Nixon-Abell, James Henderson, Pengli Zheng, Benoit Renvoise, Song Pang, C. Shan Xu, Stephan Saalfeld, Jan Funke, Yuxiang Xie, Fabian Svara, Harald F. Hess, Craig Blackstone

Summary: Researchers have generated an early onset rodent model of hereditary spastic paraplegia (HSP), which displays reliable behavioral and cellular readouts for testing novel therapies. The study reveals that in this model, the morphology of the endoplasmic reticulum (ER) undergoes changes that are linked to alterations in mitochondrial morphology and cytoskeletal organization.

HUMAN MOLECULAR GENETICS (2022)

Correction Multidisciplinary Sciences

ER proteins decipher the tubulin code to regulate organelle distribution (Mar, 10.1038/s41586-021-04204-9, 2022)

Pengli Zheng, Christopher J. Obara, Ewa Szczesna, Jonathon Nixon-Abell, Kishore K. Mahalingan, Antonina Roll-Mecak, Jennifer Lippincott-Schwartz, Craig Blackstone

NATURE (2022)

Article Multidisciplinary Sciences

Z-α1-antitrypsin polymers impose molecular filtration in the endoplasmic reticulum after undergoing phase transition to a solid state

Joseph E. Chambers, Nikita Zubkov, Marketa Kubankova, Jonathon Nixon-Abell, Ioanna Mela, Susana Abreu, Max Schwiening, Giulia Lavarda, Ismael Lopez-Duarte, Jennifer A. Dickens, Tomas Torres, Clemens F. Kaminski, Liam J. Holt, Edward Avezov, James A. Huntington, Peter St George-Hyslop, Marina K. Kuimova, Stefan J. Marciniak

Summary: This study investigates the mechanism of protein misfolding in alpha(1)-antitrypsin deficiency, leading to cirrhosis. The researchers find that alpha(1)-antitrypsin polymers undergo a phase transition, forming a protein matrix that hinders the mobility of ER proteins. This phase transition is promoted by ER stress and facilitated by the ER chaperone calreticulin. The study also reveals that immobilization of ER chaperones within the polymer matrix contributes to ER dysfunction. These findings provide insights into proteinopathies and suggest ER chaperones as potential therapeutic targets.

SCIENCE ADVANCES (2022)

Correction Multidisciplinary Sciences

Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models (vol 24, 103463, 2021)

Anny Devoy, Georgia Price, Francesca De Giorgio, Rosie Bunton-Stasyshyn, David Thompson, Samanta Gasco, Alasdair Allan, Gemma F. Codner, Remya R. Nair, Charlotte Tibbit, Ross McLeod, Zeinab Ali, Judith Noda, Alessandro Marrero-Gagliardi, Jose M. Brito-Armas, Muhammet M. Ozturk, Michelle Simon, Edward O'Neill, Sam Bryce-Smith, Jackie Harrison, Gemma Atkins, Silvia Corrochano, Michelle Stewart, Lydia Teboul, Abraham Acevedo-Arozena, Elizabeth M. C. Fisher, Thomas J. Cunningham

ISCIENCE (2022)

Article Neurosciences

Genetic Mapping of APP and Amyloid-? Biology Modulation by Trisomy 21

Paige Mumford, Justin Tosh, Silvia Anderle, Eleni Gkanatsiou Wikberg, Gloria Lau, Sue Noy, Karen Cleverley, Takashi Saito, Takaomi C. Saido, Eugene Yu, Gunnar Brinkmalm, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Victor Tybulewicz, Elizabeth M. C. Fisher, Frances K. Wiseman

Summary: This study found that in individuals with Down syndrome (DS), early onset Alzheimer's disease (AD) is associated with multiple copies of the APP gene on chromosome 21, while three copies of other genes on chromosome 21 can partially alleviate the accumulation of AP in the brain. This provides critical mechanistic insight into disease development and explains the typically later age of onset of dementia in DS individuals compared to those with familial AD caused by triplication of APP.

JOURNAL OF NEUROSCIENCE (2022)

Article Neurosciences

Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson's disease

Adamantios Mamais, Alice Kaganovich, Kirsten Harvey

Summary: Recent progress in molecular biology and genetics has advanced our understanding of the pathogenesis of Parkinson's disease (PD), highlighting synergistic relationships with inflammatory and age-related processes. Genetic risk variants and inflammation play important roles in the development of PD, and there is an overlap between genes associated with increased risk for PD and autoimmune diseases. The pathogenesis of genetic PD is related to inflammatory signaling pathways.

NEUROBIOLOGY OF DISEASE (2022)

Article Biochemistry & Molecular Biology

Regulation of membrane fluidity by RNF145-triggered degradation of the lipid hydrolase ADIPOR2

Norbert Volkmar, Christian M. Gawden-Bone, James C. Williamson, Jonathon Nixon-Abell, James A. West, Peter H. St George-Hyslop, Arthur Kaser, Paul J. Lehner

Summary: The regulation of membrane lipid composition plays a crucial role in maintaining cellular homeostasis. This study identifies proteins that differ between mammalian cells fed saturated and unsaturated fatty acids, and reveals the role of the E3 ubiquitin ligase RNF145 and lipid hydrolase ADIPOR2 in membrane lipid composition sensing and regulation. The findings provide insights into a novel autoregulatory pathway that controls cellular membrane lipid homeostasis and prevents lipotoxic stress.

EMBO JOURNAL (2022)

Article Developmental Biology

Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes

Yushi Redhead, Dorota Gibbins, Eva Lana-Elola, Sheona Watson-Scales, Lisa Dobson, Matthias Krause, Karen J. Liu, Elizabeth M. C. Fisher, Jeremy B. A. Green, Victor L. J. Tybulewicz

Summary: Down syndrome (DS) is a common human chromosomal abnormality that leads to various phenotypic features, including craniofacial dysmorphology. Through analysis of a DS mouse model and genetic mapping, it was found that four regions on mouse chromosome 16, which correspond to Hsa21 in humans, contain dosage-sensitive genes that contribute to DS craniofacial abnormalities, with Dyrk1a identified as one of the causative genes. The study revealed that the earliest and most severe defects in the DS mouse skulls occur in bones of neural crest origin, and that abnormal mineralization of the skull base synchondroses is present. Additionally, increased dosage of Dyrk1a was found to result in decreased proliferation of neural crest cells and a reduction in size and cellularity of the frontal bone primordia.

DEVELOPMENT (2023)

Article Cell Biology

Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice

Kourtney Sloan, Jared Thomas, Matthew Blackwell, Deanna Voisard, Eva Lana-Elola, Sheona Watson-Scales, Daniel L. Roper, Joseph M. Wallace, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Randall J. Roper

Summary: This study investigates the effects of triplicated genes on mouse skeletal phenotypes and finds that they can both improve and worsen bone deficits.

DISEASE MODELS & MECHANISMS (2023)

Review Neurosciences

Opinion: more mouse models and more translation needed for ALS

Elizabeth M. C. Fisher, Linda Greensmith, Andrea Malaspina, Pietro Fratta, Michael G. Hanna, Giampietro Schiavo, Adrian M. Isaacs, Richard W. Orrell, Thomas J. Cunningham, Abraham Acevedo Arozena

Summary: Amyotrophic lateral sclerosis (ALS) is a complex disorder with mostly unknown cause, but around 10% of cases are familial and caused by mutations in over 30 different genes. Mouse models exist for many genetic forms of ALS, but there is currently no model for the majority of ALS cases that are sporadic. The development of potential therapies has primarily relied on limited mouse models and has been tested on patients with different etiologies. The use of complex mouse models and patient stratification in clinical trials has proven successful in cancer research, and adopting a similar approach could lead to better understanding of ALS pathologies and faster translation of research findings into effective therapies.

MOLECULAR NEURODEGENERATION (2023)

Article Multidisciplinary Sciences

Spatially non-uniform condensates emerge from dynamically arrested phase separation

Nadia A. Erkamp, Tomas Sneideris, Hannes Ausserwoger, Daoyuan Qian, Seema Qamar, Jonathon Nixon-Abell, Peter St George-Hyslop, Jeremy D. Schmit, David A. Weitz, Tuomas P. J. Knowles

Summary: In this study, the authors investigate how biomolecular condensates can form an internal structure with dilute phase droplets via kinetic driving forces. The formation of biomolecular condensates through phase separation from proteins and nucleic acids is widely used by cells as a spatial organizational principle. This study demonstrates that complex internal architecture of condensates can arise from kinetic driving forces, providing insights into understanding and controlling the structure of condensates in vitro and in vivo.

NATURE COMMUNICATIONS (2023)

Article Biochemical Research Methods

High-fidelity 3D live-cell nanoscopy through data-driven enhanced super-resolution radial fluctuation

Romain F. Laine, Hannah S. Heil, Simao Coelho, Jonathon Nixon-Abell, Angelique Jimenez, Theresa Wiesner, Damian Martinez, Tommaso Galgani, Louise Regnier, Aki Stubb, Gautier Follain, Samantha Webster, Jesse Goyette, Aurelien Dauphin, Audrey Salles, Sian Culley, Guillaume Jacquemet, Bassam Hajj, Christophe Leterrier, Ricardo Henriques

Summary: This article presents an enhanced super-resolution radial fluctuations (eSRRF) method that improves image fidelity and resolution. The method incorporates automated parameter optimization and has been validated across various imaging modalities and biological systems. Additionally, eSRRF has been extended to three dimensions by combining it with multifocus microscopy, enabling live-cell volumetric super-resolution imaging.

NATURE METHODS (2023)

No Data Available